UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
Commission File Number: 0-19352
NOTIFICATION OF LATE FILING OF FORM 10-Q
For the Period Ended: September 30, 1999
PART 1. REGISTRANT INFORMATION
Full name of registrant: AgriBioTech, Inc.
-----------------
Former name if applicable: N/A
---
Address of Principal executive office (Street and number):
120 Corporate Park Drive
- ------------------------
City, State and Zip Code: Henderson, Nevada 89014
------------------------
PART II. RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense, and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
[ X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[ X] (b) The subject quarterly report on Form 10-Q will be filed on or before
the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III. NARRATIVE
State below in reasonable detail the reasons why the Form 10-Q could not be
filed within the prescribed time period:
SFAS No. 131 "Disclosures about Segments of an Enterprise and Related
Information" requires the Registrant to provide certain quarterly data regarding
its operating segments for the first time in the September 30, 1999 Form 10-Q.
Due to the Registrant's recent organizational changes, including the
restructuring of the 34 companies acquired since January 1, 1995 into business
units, and the rollout of a new information system, the Registrant is unable to
complete and file its Form 10-Q within the prescribed time period without
unreasonable effort and expense.
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
<PAGE>
Randy Ingram (702) 566-2440
(Name) (Area Code) (Telephone number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding 12 months or for such
shorter period that the registrant was required to file such reports(s) been
filed? If the answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
The Company estimates that it will report a net loss of approximately $3.6
million or $(0.07) per share in the three-month period ended September 30, 1999,
compared to net earnings of approximately $0.3 million, or $0.01 per share in
the corresponding three-month period ended September 30, 1998. Average
outstanding fully diluted common shares for the three-month period ended
September 31, 1999 were 48.4 million compared to 41.3 million for the
three-month period ended September 30, 1998.
AgriBioTech, Inc.
-------------------------------------------
(Name of registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: November 15, 1999 By: /s/ Randy Ingram
------------------------------
Randy Ingram
Title: Executive Vice President/CFO
Instruction: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. If the statement is signed on
behalf of the registrant by an authorized representative (other than an
executive officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
ATTENTION:
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
